相似文献
1
Review of Automated Insulin Delivery Systems for Individuals with Type 1 Diabetes: Tailored Solutions for Subpopulations.
Curr Opin Biomed Eng. 2021 Sep;19. doi: 10.1016/j.cobme.2021.100312. Epub 2021 Jun 18.
2
Characterizing Glycemic Control and Sleep in Adults with Long-Standing Type 1 Diabetes and Hypoglycemia Unawareness Initiating Hybrid Closed Loop Insulin Delivery.
J Diabetes Res. 2021 Feb 12;2021:6611064. doi: 10.1155/2021/6611064. eCollection 2021.
3
Why #WeAreNotWaiting-Motivations and Self-Reported Outcomes Among Users of Open-source Automated Insulin Delivery Systems: Multinational Survey.
J Med Internet Res. 2021 Jun 7;23(6):e25409. doi: 10.2196/25409.
4
Practical Guidance on Open Source and Commercial Automated Insulin Delivery Systems: A Guide for Healthcare Professionals Supporting People with Insulin-Requiring Diabetes.
Diabetes Ther. 2022 Sep;13(9):1683-1699. doi: 10.1007/s13300-022-01299-9. Epub 2022 Aug 1.
5
Assessment of Risks and Benefits of Beta Cell Replacement Versus Automated Insulin Delivery Systems for Type 1 Diabetes.
Curr Diab Rep. 2020 Aug 31;20(10):52. doi: 10.1007/s11892-020-01339-3.
6
(Hybrid) Closed-Loop Systems: From Announced to Unannounced Exercise.
Diabetes Technol Ther. 2023 Dec 22. doi: 10.1089/dia.2023.0293.
7
Toward Automation of Insulin Delivery - Management Solutions for Type 1 Diabetes.
Endocr Dev. 2016;30:1-13. doi: 10.1159/000439321. Epub 2015 Dec 10.
8
Association of British Clinical Diabetologists, Diabetes Technology Network UK and Association of Children's Diabetes Clinicians Survey of UK Healthcare Professional Attitudes Towards Open-Source Automated Insulin Delivery Systems.
Diabetes Ther. 2022 Feb;13(2):341-353. doi: 10.1007/s13300-022-01203-5. Epub 2022 Jan 31.
9
Real-world evidence on clinical outcomes of people with type 1 diabetes using open-source and commercial automated insulin dosing systems: A systematic review.
Diabet Med. 2022 May;39(5):e14741. doi: 10.1111/dme.14741. Epub 2021 Nov 24.
10
Advances in Closed-Loop Insulin Delivery Systems in Patients with Type 1 Diabetes.
Curr Diab Rep. 2018 Aug 29;18(10):88. doi: 10.1007/s11892-018-1051-z.
引用本文的文献
1
Effectiveness of continuous glucose monitoring systems on glycemic control in adults with type 1 diabetes: A systematic review and meta-analysis.
Metabol Open. 2025 Jul 29;27:100382. doi: 10.1016/j.metop.2025.100382. eCollection 2025 Sep.
2
Daytime and nighttime glycemic control with control-IQ technology vs. standard therapy in type 1 diabetes: a systematic review and meta-analysis with trial sequential analysis and GRADE assessment.
Diabetol Metab Syndr. 2025 Aug 12;17(1):325. doi: 10.1186/s13098-025-01906-2.
3
Personalized Model Identification for Glucose Dynamics From Clinical Data With Incomplete Inputs.
IEEE Trans Biomed Eng. 2025 Jun;72(6):2001-2012. doi: 10.1109/TBME.2025.3530711.
4
Advancements in Insulin Pumps: A Comprehensive Exploration of Insulin Pump Systems, Technologies, and Future Directions.
Pharmaceutics. 2024 Jul 15;16(7):944. doi: 10.3390/pharmaceutics16070944.
5
Impact on Glycemia Risk Index and other metrics in type 1 adult patients switching to Advanced Hybrid Closed-Loop systems: a one-year real-life experience.
Eur J Med Res. 2024 Jul 15;29(1):365. doi: 10.1186/s40001-024-01946-w.
6
Enhancing equity in access to automated insulin delivery systems in an ethnically and socioeconomically diverse group of children with type 1 diabetes.
BMJ Open Diabetes Res Care. 2024 May 15;12(3):e004045. doi: 10.1136/bmjdrc-2024-004045.
7
Glucose Rate-of-Change and Insulin-on-Board Jointly Weighted Zone Model Predictive Control.
IEEE Trans Control Syst Technol. 2023 Sep;31(5):2261-2274. doi: 10.1109/tcst.2023.3291573. Epub 2023 Jul 31.
8
Ketone-Based Alert System for Insulin Pump Failures.
J Diabetes Sci Technol. 2025 May;19(3):683-691. doi: 10.1177/19322968231209339. Epub 2023 Nov 9.
9
Enabling fully automated insulin delivery through meal detection and size estimation using Artificial Intelligence.
NPJ Digit Med. 2023 Mar 13;6(1):39. doi: 10.1038/s41746-023-00783-1.
10
Design of a Real-Time Physical Activity Detection and Classification Framework for Individuals With Type 1 Diabetes.
J Diabetes Sci Technol. 2024 Sep;18(5):1146-1156. doi: 10.1177/19322968231153896. Epub 2023 Feb 17.
本文引用的文献
1
New closed-loop insulin systems.
Diabetologia. 2021 May;64(5):1007-1015. doi: 10.1007/s00125-021-05391-w. Epub 2021 Feb 6.
2
A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial.
Lancet. 2021 Jan 16;397(10270):208-219. doi: 10.1016/S0140-6736(20)32514-9.
3
The Impact of a Recently Approved Automated Insulin Delivery System on Glycemic, Sleep, and Psychosocial Outcomes in Older Adults With Type 1 Diabetes: A Pilot Study.
J Diabetes Sci Technol. 2022 May;16(3):663-669. doi: 10.1177/1932296820986879. Epub 2021 Jan 15.
4
Carbohydrate Requirements for Prolonged, Fasted Exercise With and Without Basal Rate Reductions in Adults With Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion.
Diabetes Care. 2021 Feb;44(2):610-613. doi: 10.2337/dc20-1554. Epub 2020 Dec 16.
5
14. Management of Diabetes in Pregnancy: .
Diabetes Care. 2021 Jan;44(Suppl 1):S200-S210. doi: 10.2337/dc21-S014.
6
13. Children and Adolescents: .
Diabetes Care. 2021 Jan;44(Suppl 1):S180-S199. doi: 10.2337/dc21-S013.
7
12. Older Adults: .
Diabetes Care. 2021 Jan;44(Suppl 1):S168-S179. doi: 10.2337/dc21-S012.
8
Real-World Patient-Reported Outcomes and Glycemic Results with Initiation of Control-IQ Technology.
Diabetes Technol Ther. 2021 Feb;23(2):120-127. doi: 10.1089/dia.2020.0388. Epub 2020 Sep 10.
9
A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes.
N Engl J Med. 2020 Aug 27;383(9):836-845. doi: 10.1056/NEJMoa2004736.
10
The competitive athlete with type 1 diabetes.
Diabetologia. 2020 Aug;63(8):1475-1490. doi: 10.1007/s00125-020-05183-8. Epub 2020 Jun 12.
Zotero 插件